Dawnrays Pharmaceutical (Holdings) Limited
HKEX:2348.HK
1.25 (HKD) • At close November 13, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Dawnrays Pharmaceutical (Holdings) Limited |
Symbool | 2348.HK |
Munteenheid | HKD |
Prijs | 1.25 |
Beurswaarde | 1,877,212,500 |
Dividendpercentage | 7.74% |
52-weken bereik | 1 - 1.4 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Ms. Kei Ling Li |
Website | https://www.dawnrays.com |
An error occurred while fetching data.
Over Dawnrays Pharmaceutical (Holdings) Limited
Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics. It also provides
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (HKD)
Cijfers zijn in miljoenen (HKD)